Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania

Journal of Clinical Microbiology

Volumn 44, Issue 8, 2006, Pages 2801-2807

  Kasubi, Mabula Joseph ^a,b   Nilsen, Arvid ^c   Marsden, Howard S ^d   Bergström, Tomas ^e   Langeland, Nina ^c   Haarr, Lars ^a,f  

^a UNIVERSITY OF BERGEN   (Norway)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d INSTITUTE OF VIROLOGY   (United Kingdom)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VIRUS 1 ANTIBODY; HERPES SIMPLEX VIRUS 2 ANTIBODY; THROMBOSPONDIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CHILD; EPITOPE MAPPING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; SEXUAL TRANSMISSION; STATISTICAL SIGNIFICANCE; TANZANIA; URBAN AREA; VIRUS TRANSMISSION; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HIV; HUMANS; INFANT; MALE; SEROEPIDEMIOLOGIC STUDIES; STATISTICS; TANZANIA; URBAN POPULATION;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS; SIMPLEXVIRUS;

EID: 33747237578     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00180-06     Document Type: Article

References (44)

1. Ashley, R. L. 2001. Sorting out the new HSV type specific antibody tests. Sex. Transm. Infect. 77:232-237.
2. Ashley, R. L., J. Miltoni, F. Lee, A. Nahmias, and L. Corey. 1988. Comparison of Western blot (immunoblot) and G-specific immunodot enzyme assays for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 26:662-667.
3. Beelaert, G., G. Vercautern, K. Fransen, M. Mangelschots, M. De Rooy, S. Garcia-Ribs, and G. van Groen. 2002. Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV. J. Virol. Methods 105:197-206.
4. Brown, S. M., D. A. Ritchie, and J. H. Subal-Sharpe. 1973. Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangements into complementation groups and recombination analysis leading to a linkage map. J. Gen. Virol. 18:329-346.
5. Brown, Z. A., J. Benedetti, R. Ashley, S. Burchett, S. Selke, S. Berry, L. A. Vontver, and L. Corey. 1991. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labour. N. Engl. J. Med. 324:1247-1252.
6. Brugha, R., K. Keersmaekers, and A. Renton. 1997. Genital herpes infection: a review. Int. J. Epidemiol. 26:698-709.
7. Cohen, M. S. 1998. Sexually transmitted diseases enhance HIV transmission: no longer hypothesis. Lancet 351(Suppl. 111):5-7.
8. Corey, L., and H. H. Handsfield. 2000. Genital herpes and public health. Addressing a global problem. JAMA 283:791-794.
9. Fleming, D. T., G. M. McQuillan, R. E. Johnson, A. J. Nahmias, S. O. Aral, F. K. Lee, and M. E. St. Louis. 1997. Herpes simplex virus type 2 in the United States, 1967 to 1994. N. Engl. J. Med. 337:1105-1111.
10. Ghebrekidan, H., U. Ruden, S. Cox, B. Wahren, and M. Grandien. 1999. Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J. Clin. Virol. 12:53-64.
11. Hashido, M., F. K. Lee, A. J. Nahmias, H. Tsugami, S. Isomura, Y. Nagata, S. Sonoda, and T. Kawana. 1998. An epidemiologic study of herpes simplex virus type 1 and 2 infection in Japan based on type-specific serological assays. Epidemiol. Infect. 120:179-186.
12. Ho, D. W. T., P. R. Field, E. Sjögren-Jansson, S. Jeansson, and A. L. Cunningham. 1992. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J. Virol. Methods 36:249-264.
13. Hogrefe, W., J. Su, J. Song, R. Ashley, and L. Kong. 2002. Detection of herpes simplex virus type 2-specific immunoglobulin antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition. J. Clin. Microbiol. 40:3635-3640.
14. Jonsson, M. K., and B. Wahren. 2004. Sexually transmitted herpes simplex. Scand. J. Infect. Dis. 36:93-101.
15. Kangro, H. O., H. K. Osman, Y. L. Lau, R. B. Heath, C. Y. Yeung, and M. H. Ng. 1994. Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J. Med. Virol. 43:91-96.
16. Kasubi, M. J., A. Nilsen, H. S. Marsden, T. Bergström, N. Langeland, and L. Haarr. 2005. A branched, synthetic oligopeptide corresponding to a region of glycoprotein G of HSV-1 reacts sensitively and specifically with HSV-1 antibodies in an ELISA J. Virol. Methods 125:137-143.
17. Kieff, E., B. Hoyer, S. Bachenheimer, and B. Roizman. 1972. Genetic relatedness of type 1 and type 2 herpes simplex viruses. J. Virol. 9:738-745.
18. Koutsky, L. A., R. L. Ashley, and K. K. Holmes. 1990. The frequency of unrecognized type 2 herpes simplex virus among women. Implications for the control of genital herpes. Sex. Transm. Dis. 17:90-94.
19. Lafferty, W. E., L. Downey, C. Celum, and A. Wald. 2000. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J. Infect. Dis. 181:1454-1457.
20. Langeland, N., L. Haarr, and F. Mhalu. 1998. Prevalence of HSV-2 antibodies among STD clinic patients in Tanzania. Int. J. STD AIDS 9:104-107.
21. Liljeqvist, J.-Å., E. Trybala, B. Svennerholm, S. Jeansson, E. Sjögren-Jansson, and T. Bergström. 1998. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J. Gen. Virol. 79:1215-1224.
22. Löwhagen, G. B., P. Tunbäck, and T. Bergström. 2002. Proportion of herpes simplex virus (HSV) type 1 and 2 among genital and extragenital HSV isolates. Acta Dermato-Venereol. 82:118-120.
23. Löwhagen, G. B., P. Tunbäck, K. Andersson, T. Bergström, and G. Johannison. 2000. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex. Transm. Infect. 27:425-430.
24. Marsden, H. S., K. MacAulay, J. Murray, and I. W. Smith. 1998. Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis. J. Med. Virol. 56:79-84.
25. Marsden, H. S., A. Buckmaster, J. W. Palfreyman, R. G. Hope, and A. C. Minson. 1984. Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J. Virol. 50:547-554.
26. Mertz, G. J., O. Schmidt, and J. L. Jourden. 1985. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contact. Sex. Transm. Dis. 12:33-39.
27. Mertz, G. J., R. W. Coombs, and R. Ashley. 1988. Unrecognized transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J. Infect. Dis. 157:1169-1177.
28. Morse, S. A., D. L. Trees, Y. Htun, F. Radebe, K. A. Orle, Y. Dangor, C. M. Beck-Sague, S. Schmid, G. Fehler, J. B. Weiss, and R. C. Ballard. 1997. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J. Infect. Dis. 175:583-589.
29. Nahmias, A. J., F. K. Lee, and S. Beckman-Nahmias. 1990. Sero-epidemiology and -sociological patterns of herpes simplex virus infection in the world. Scand. J. Infect. Dis. 69(Suppl.):19-36.
30. Nilsen, A., and H. Myrmel. 2000. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet. Gynecol. Scand. 79:693-696.
31. Nilsen, A., E. Ulvestad, H. Marsden, N. Langeland, H. Myrmel, R. Matre, and L. Haarr. 2003. Performance characteristics of a glycoprotein G based oligopeptide (peptide 55) and two different methods using the complete glycoprotein as assays for detection of anti-HSV-2 antibodies in human sera. J. Virol. Methods 107:21-27.
32. Nilsen, A., D. Mwakagile, H. Marsden, N. Langeland, R. Matre, and L. Haarr. 2005. Prevalence of, and risk factors for, HSV-2 antibodies in sexually transmitted disease patients, healthy pregnant females, blood donors and medical students in Tanzania and Norway. Epidemiol. Infect. 133:915-925.
33. Oladepo, D. K., P. E. Klapper, and H. Marsden. 2000. Peptide based enzyme-linked immunoassays for detection of anti-HSV-2 IgG in human sera. J. Virol. Methods 87:63-70.
34. Richman, D. D., A. Buckmaster, S. Bell, C. Hodgman, and A. C. Minson. 1986. Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. J. Virol. 57:647-655.
35. Smith, J. S., and J. Robinson. 2002. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 186:S3-S28.
36. Sommerfell, M. A., I. Ohlsson, I. Flolid, R. Thorstensson, and B. Sorensen. 2004. A simple semi-rapid HIV-1 and 2 confirmatory immunoassay using magnetic particles. J. Virol. Methods 115:191-198.
37. Thompson, C. 2000. Genital herpes simplex typing in genitourinary medicine: 1995-1999. Int. J. STD AIDS 11:501-502.
38. Timbury, M. C. 1971. Temperature-sensitive mutants of herpes simplex virus type 2. J. Gen. Virol. 13:373-376.
39. Tunbäck, P., T. Bergström, A. S. Andersson, P. Nordin, I. Krantz, and G. B. Löw hagen. 2003. Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross-sectional study. Scand. J. Infect. Dis. 35:498-502.
40. Uusküla, A., M. Nygard-Kibur, F. M. Cowan, P. Mayaud, R. S. French, J. N. R. Robinson, and D. W. G. Brown. 2004. The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia. Scand. J. Infect. Dis. 36:727-732.
41. Vyse, A. J., N. J. Gay, M. J. Slomka, R. Gropal, T. Gibbs, P. Morgan-Capner, and D. W. Brown. 2000. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex. Transm. Infect. 76:183-187.
42. Whitley, R. J., L. Corey, and A. Arvin. 1998. Changing presentation of herpes simplex virus infection in neonates. J. Infect. Dis. 158:109-116.
43. Wutzler, P., H. W. Doerr, I. Färber, U. Eichhorn, B. Heibig, A. Sauerbrei, A. Brandstädt, and H. Rebenau. 2000. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J. Med. Virol. 61:201-207.
44. Zweig, M. H., and G. Campbell. 1993. Receiver-operating characteristics (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39:561-577.